Atlas Trials

Brolucizumab Efficacy and Safety Single-Arm Descriptive Trial in Patients With Persistent Diabetic Macular Edema

Clinical trial NCT06498050 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06498050
Sponsor
Guangdong Provincial People's Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Macular Edema
Start date
2024-07-10
Primary completion
2025-07-10
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.